Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001963 |
---|---|
Receipt number | R000002392 |
Scientific Title | Phase II clinical trial of the third-line Cetuximab and irinotecan or Cetuximab therapy for patients with KRAS wild type unresectable/recurrent colorectal cancer |
Date of disclosure of the study information | 2009/05/13 |
Last modified on | 2009/05/12 23:14:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/05/12 23:15:44 |